Literature DB >> 31655411

Tau progression in single severe frontal traumatic brain injury in human brains.

Yasushi Okamura1, Ito Kawakami2, Katsushige Watanabe3, Kenichi Oshima4, Kazuhiro Niizato4, Kenji Ikeda5, Haruhiko Akiyama5, Masato Hasegawa5.   

Abstract

The neuropathological features of chronic traumatic encephalopathy (CTE), caused by repeated traumatic brain injury (TBI), include abnormal accumulations of hyper-phosphorylated tau (p-tau) protein in neurons, neurites and astrocytes, considered to progress via neuronal circuits in brains. Some previous reports suggest that a single severe TBI (sTBI) can also induce CTE and p-tau accumulation, but it is not clear whether the pathology is the same as that of repetitive TBI (rTBI). Since prefrontal leucotomy could be regarded as a model of sTBI, in this study we evaluated two autopsied schizophrenia with this procedure. Histopathologically, gliosis and neuronal loss were found not only in the primary ablated prefrontal region, but also in secondary affected areas, i.e., cingulate gyrus, medial nucleus of the thalamus, and nucleus accumbens, which are connected to prefrontal areas. Accumulation of p-tau was mostly seen in neurons, neurites and glias around small blood vessels in the leucotomized prefrontal region. In addition, secondary regions showed some p-tau-positive neurons/glias, as well as many axonal spheroids. Regions of neuronal/glial p-tau pathology showed immunoreactivity to both 3R/4R tau antibodies. Immunoblot analyses of sarkosyl-insoluble tau from frozen brains showed an AD-type tau banding pattern with strong immunoreactivities. sTBI patients showed limited comorbidities, such as TDP-43, alpha-synuclein or AD pathology, whereas rTBI patients have high frequencies of them. The findings suggest that p-tau in the primary affected lesion might progress to connected regions via neuronal circuits over time, and a single severe axonal injury might lead to CTE pathology different from that caused by rTBI.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Accumulation; Chronic traumatic encephalopathy; Pathology; Progression; Strain; Tau; Traumatic brain injury

Year:  2019        PMID: 31655411     DOI: 10.1016/j.jns.2019.116495

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Reducing acetylated tau is neuroprotective in brain injury.

Authors:  Min-Kyoo Shin; Edwin Vázquez-Rosa; Yeojung Koh; Matasha Dhar; Kalyani Chaubey; Coral J Cintrón-Pérez; Sarah Barker; Emiko Miller; Kathryn Franke; Maria F Noterman; Divya Seth; Rachael S Allen; Cara T Motz; Sriganesh Ramachandra Rao; Lara A Skelton; Machelle T Pardue; Steven J Fliesler; Chao Wang; Tara E Tracy; Li Gan; Daniel J Liebl; Jude P J Savarraj; Glenda L Torres; Hilda Ahnstedt; Louise D McCullough; Ryan S Kitagawa; H Alex Choi; Pengyue Zhang; Yuan Hou; Chien-Wei Chiang; Lang Li; Francisco Ortiz; Jessica A Kilgore; Noelle S Williams; Victoria C Whitehair; Tamar Gefen; Margaret E Flanagan; Jonathan S Stamler; Mukesh K Jain; Allison Kraus; Feixiong Cheng; James D Reynolds; Andrew A Pieper
Journal:  Cell       Date:  2021-04-13       Impact factor: 41.582

Review 2.  Space-occupying brain lesions, trauma-related tau astrogliopathy, and ARTAG: a report of two cases and a literature review.

Authors:  Adam D Bachstetter; Filip G Garrett; Gregory A Jicha; Peter T Nelson
Journal:  Acta Neuropathol Commun       Date:  2021-03-23       Impact factor: 7.801

Review 3.  Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43.

Authors:  Airi Tarutani; Tadashi Adachi; Hiroyasu Akatsu; Yoshio Hashizume; Kazuko Hasegawa; Yuko Saito; Andrew C Robinson; David M A Mann; Mari Yoshida; Shigeo Murayama; Masato Hasegawa
Journal:  Acta Neuropathol       Date:  2022-05-05       Impact factor: 15.887

4.  Association between single moderate to severe traumatic brain injury and long-term tauopathy in humans and preclinical animal models: a systematic narrative review of the literature.

Authors:  Jose Abisambra; Steven T DeKosky; Ariel Walker; Ben Chapin
Journal:  Acta Neuropathol Commun       Date:  2022-01-31       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.